Literature DB >> 16188987

Host cell nuclear proteins are recruited to cytoplasmic vaccinia virus replication complexes.

Jaewook Oh1, Steven S Broyles.   

Abstract

The initiation and termination of vaccinia virus postreplicative transcription have been reported to require cellular proteins, some of which are believed to be nuclear proteins. Vaccinia virus replicates in the cytoplasmic compartment of the cell, raising questions as to whether vaccinia virus has access to nuclear proteins. This was addressed here by following the fate of several nuclear proteins after infection of cells with vaccinia virus. The nuclear transcription factors YY1, SP1, and TATA binding protein were found to colocalize with virus replication complexes in the cytoplasm of infected cells. In addition, the nuclear proteins RNA polymerase II, TAFIIp32, and histone deacetylase 8, but not the structural protein lamin B, also were found in the cytoplasm of the cell. The association of YY1 with replication complexes was dependent on DNA replication and required only the DNA binding domain of the protein, indicating that DNA binding alone may be responsible for the association of nuclear transcription factors with viral replication complexes in the cytoplasm. The cytoplasmic localization of YY1 was resistant to the nuclear export inhibitor leptomycin B. Evidence is presented indicating that nuclear import and export pathways were not adversely affected by vaccinia virus infection. These observations indicate that vaccinia virus replication complexes have ready access to nuclear proteins by allowing leakage from the nucleus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188987      PMCID: PMC1235867          DOI: 10.1128/JVI.79.20.12852-12860.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Vaccinia virus late transcription is activated in vitro by cellular heterogeneous nuclear ribonucleoproteins.

Authors:  C F Wright; B W Oswald; S Dellis
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

Review 2.  Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle.

Authors:  Karsten Weis
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

3.  Detection of a subunit of cellular Pol II within highly purified preparations of RNA polymerase isolated from rabbit poxvirus virions.

Authors:  D K Morrison; R W Moyer
Journal:  Cell       Date:  1986-02-28       Impact factor: 41.582

4.  Preparation of extracts from higher eukaryotes.

Authors:  J D Dignam
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

5.  Transcription factor YY1 is a vaccinia virus late promoter activator.

Authors:  S S Broyles; X Liu; M Zhu; M Kremer
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

6.  Reconstitution of HIV-1 rev nuclear export: independent requirements for nuclear import and export.

Authors:  D C Love; T D Sweitzer; J A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  YY1 is recruited to the cytoplasm of vaccinia virus-infected human macrophages by the Crm1 system.

Authors:  Kinga Slezak; Marta Michalik; Aleksandra Kowalczyk; Hanna Rokita
Journal:  Virus Res       Date:  2004-06-15       Impact factor: 3.303

Review 8.  Vaccinia virus transcription.

Authors:  Steven S Broyles
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

9.  Relationship between RNA polymerase II and efficiency of vaccinia virus replication.

Authors:  S Wilton; S Dales
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

Review 10.  Regulation of viral transcription elongation and termination during vaccinia virus infection.

Authors:  Richard C Condit; Edward G Niles
Journal:  Biochim Biophys Acta       Date:  2002-09-13
View more
  23 in total

1.  Vaccinia-like cytoplasmic replication of the giant Mimivirus.

Authors:  Yael Mutsafi; Nathan Zauberman; Ilana Sabanay; Abraham Minsky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

2.  Molecular characterization of the host defense activity of the barrier to autointegration factor against vaccinia virus.

Authors:  Nouhou Ibrahim; April Wicklund; Matthew S Wiebe
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology.

Authors:  Patrícia N G Silva; Jamária A P Soares; Bruno S A F Brasil; Sarah V Nogueira; Anderson A Andrade; José C de Magalhães; Marisa B Bonjardim; Paulo C P Ferreira; Erna G Kroon; Oscar Bruna-Romero; Cláudio A Bonjardim
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

4.  Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein.

Authors:  Bruce A Knutson; Xu Liu; Jaewook Oh; Steven S Broyles
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus.

Authors:  Ann Chahroudi; David A Garber; Patrick Reeves; Luzheng Liu; Daniel Kalman; Mark B Feinberg
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

6.  Identifying Host Factors Associated with DNA Replicated During Virus Infection.

Authors:  Emigdio D Reyes; Katarzyna Kulej; Neha J Pancholi; Lisa N Akhtar; Daphne C Avgousti; Eui Tae Kim; Daniel K Bricker; Lynn A Spruce; Sarah A Koniski; Steven H Seeholzer; Stuart N Isaacs; Benjamin A Garcia; Matthew D Weitzman
Journal:  Mol Cell Proteomics       Date:  2017-10-02       Impact factor: 5.911

Review 7.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

8.  Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus.

Authors:  Jason Farlow; Mohamed Ait Ichou; John Huggins; Sofi Ibrahim
Journal:  Virol J       Date:  2010-05-28       Impact factor: 4.099

9.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

10.  Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.

Authors:  Aodhnait S Fahy; Richard H Clark; Emily F Glyde; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.